Coronavirus Infection Treatment: Newly Granted Patent for Compounds and Methods by Sunshine Biopharma
Sunshine Biopharma’s newly granted U.S. Patent (12,624,066 B2) covers a novel approach to treating coronavirus infections, marking a potential advancement in antiviral therapies. The innovation centers on a compound targeting ... Read More